Clinical Trial Update: Furosemide in Early Acute Kidney Injury [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates that a Phase 2/Phase 3 study evaluating furosemide for early acute kidney injury has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: University of Alberta | Conditions: Acute Renal Failure | Phase 2, Phase 3 | Status: TERMINATED